132 related articles for article (PubMed ID: 238480)
1. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
[TBL] [Abstract][Full Text] [Related]
2. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
[TBL] [Abstract][Full Text] [Related]
3. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
[TBL] [Abstract][Full Text] [Related]
4. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
Marchi F; Ciriello G
Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
[TBL] [Abstract][Full Text] [Related]
6. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
[TBL] [Abstract][Full Text] [Related]
8. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
[TBL] [Abstract][Full Text] [Related]
9. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
10. [Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension: the effect of atenolol (author's transl)].
Philipp T; Cordes U; Distler A
Dtsch Med Wochenschr; 1977 Apr; 102(15):569-74. PubMed ID: 14816
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients.
Amery A; Billiet L; Boel A; Fagard R; Reybrouck T; Willems J
Am Heart J; 1976 May; 91(5):634-42. PubMed ID: 773142
[TBL] [Abstract][Full Text] [Related]
12. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
14. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
15. Clinical and hemodynamic effects of celiprolol in essential hypertension.
Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of the beta-blocker chlorpropanol (tobanum) in hypertension patients].
Sirakova V; Penkov N; Kaponov Kh
Vutr Boles; 1986; 25(1):35-41. PubMed ID: 2872751
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
Silke B; Guy S; Humphreys JE
J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
[TBL] [Abstract][Full Text] [Related]
18. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
[TBL] [Abstract][Full Text] [Related]
19. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].
Herpin D; Boutaud P; Ciber MA; Amiel A; Demange J
Ann Cardiol Angeiol (Paris); 1987 Nov; 36(9):487-93. PubMed ID: 2892458
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]